Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro
- PMID: 1313908
- PMCID: PMC241048
- DOI: 10.1128/JVI.66.5.2893-2903.1992
Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro
Abstract
Recombinant Epstein-Barr viruses with a stop codon inserted into the nuclear protein 3B (EBNA 3B) open reading frame were generated by second-site homologous recombination. These mutant viruses infected and growth transformed primary B lymphocytes, resulting in the establishment of lymphoblastoid cell lines (LCLs). Polymerase chain reaction analysis and Southern hybridizations with infected cell DNA demonstrated the presence of the mutant EBNA 3B and the absence of wild-type EBNA 3B. Immunoblot analysis of the LCLs with affinity-purified EBNA 3B antibodies confirmed the absence of EBNA 3B cross-reactive protein. Virus was reactivated from two of these infected LCLs and serially passaged through primary B lymphocytes. The newly infected cells contained only the mutant recombinant virus. No difference was noted between mutant and wild-type recombinants, derived in parallel, in latent (other than EBNA 3B) or lytic cycle-infected cell virus protein expression or in the growth of the latently infected transformed cell lines. These data indicate that the EBNA 3B protein is not critical for primary B-lymphocyte infection, growth transformation, or lytic virus infection in vitro.
Similar articles
-
Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.J Virol. 1993 Apr;67(4):2014-25. doi: 10.1128/JVI.67.4.2014-2025.1993. J Virol. 1993. PMID: 8445720 Free PMC article.
-
The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.J Virol. 1991 Dec;65(12):6826-37. doi: 10.1128/JVI.65.12.6826-6837.1991. J Virol. 1991. PMID: 1658376 Free PMC article.
-
Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.J Virol. 1992 Feb;66(2):780-9. doi: 10.1128/JVI.66.2.780-789.1992. J Virol. 1992. PMID: 1309912 Free PMC article.
-
Immortalizing genes of Epstein-Barr virus.Adv Virus Res. 1991;40:19-55. doi: 10.1016/s0065-3527(08)60276-6. Adv Virus Res. 1991. PMID: 1659776 Review.
-
Role of EBNA-3 Family Proteins in EBV Associated B-cell Lymphomagenesis.Front Microbiol. 2016 Apr 7;7:457. doi: 10.3389/fmicb.2016.00457. eCollection 2016. Front Microbiol. 2016. PMID: 27092119 Free PMC article. Review.
Cited by
-
T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display.PLoS Pathog. 2009 Dec;5(12):e1000699. doi: 10.1371/journal.ppat.1000699. Epub 2009 Dec 18. PLoS Pathog. 2009. PMID: 20019813 Free PMC article.
-
The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.Mol Pathol. 2000 Oct;53(5):270-9. doi: 10.1136/mp.53.5.270. Mol Pathol. 2000. PMID: 11091851 Free PMC article. Review.
-
An Epstein-Barr virus protein interacts with Notch.J Virol. 2001 Jan;75(1):384-95. doi: 10.1128/JVI.75.1.384-395.2001. J Virol. 2001. PMID: 11119607 Free PMC article.
-
Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis.Front Oncol. 2018 Aug 2;8:265. doi: 10.3389/fonc.2018.00265. eCollection 2018. Front Oncol. 2018. PMID: 30116721 Free PMC article. Review.
-
The Epstein-Barr virus and its association with human cancers.Mol Pathol. 1999 Dec;52(6):307-22. doi: 10.1136/mp.52.6.307. Mol Pathol. 1999. PMID: 10748864 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources